Showing results (51-60 of 148) with videos related to

Sort By:
Pageof 15
Cancer|August 5, 2020
Pharmacokinetics, safety, and activity of trabectedin as first-line treatment in elderly patients who are affected by advanced sarcoma and are unfit to receive standard chemotherapy: A phase 2 study (TR1US study) from the Italian Sarcoma GroupFederica Grosso, Lorenzo D'Ambrosio, Massimo Zucchetti, et al.
Cells|November 4, 2020
High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: A Retrospective SeriesEmanuela Palmerini, Elisabetta Setola, Giovanni Grignani, et al.
Cancer|January 13, 2022
Weekly cisplatin with or without imatinib in advanced chordoma: A retrospective case-series analysis from the Italian Rare Cancers NetworkGiacomo G Baldi, Salvatore Lo Vullo, Giovanni Grignani, et al.
ESMO Open|August 28, 2020
Evaluation of the use and efficacy of (neo)adjuvant chemotherapy in angiosarcoma: a multicentre studyAnastasia Constantinidou, Nicolas Sauve, Silvia Stacchiotti, et al.
Cancers|December 24, 2021
PARP1 Inhibitor and Trabectedin Combination Does Not Increase Tumor Mutational Burden in Advanced Sarcomas-A Preclinical and Translational StudyYmera Pignochino, Giovanni Crisafulli, Giorgia Giordano, et al.
European Journal of Radiology Open|July 24, 2023
A mutation-based radiomics signature predicts response to imatinib in Gastrointestinal Stromal Tumors (GIST)Giovanni Cappello, Valentina Giannini, Roberto Cannella, et al.
The Lancet. Oncology|December 16, 2014
Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trialGiovanni Grignani, Emanuela Palmerini, Virginia Ferraresi, et al.
Genes, Chromosomes & Cancer|March 20, 2019
Gain of FGF4 is a frequent event in KIT/PDGFRA/SDH/RAS-P WT GISTMilena Urbini, Valentina Indio, Giuseppe Tarantino, et al.
International Journal of Cancer|July 26, 2021
Avelumab expanded access program in metastatic Merkel cell carcinoma: Efficacy and safety findings from patients in Europe and the Middle EastPaolo Antonio Ascierto, Kristina Orlova, Giovanni Grignani, et al.
Therapeutic Advances in Medical Oncology|September 6, 2018
Imatinib rechallenge in patients with advanced gastrointestinal stromal tumors following progression with imatinib, sunitinib and regorafenibBruno Vincenzi, Margherita Nannini, Giuseppe Badalamenti, et al.
Pageof 15